Navigation Links
New Class of Instruments for Flexible Surgery from Apollo Endosurgery® Used in Cancer Therapy

AUSTIN, Texas, April 19, 2011 /PRNewswire/ -- Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain. This is a stark contrast to minimally invasive or open surgeries which necessitate incisions and can require anywhere  from two to eight weeks of recovery time.

"Revolutionary cases like this one begin to reveal the potential of new flexible surgery techniques and tools designed to remove early stage lesions from the colon, esophagus, and stomach," says Jay Redan, MD, Medical Director of Minimally Invasive Surgery at Florida Hospital Celebration Health.

Development of flexible surgical instruments like the one used at Florida Hospital could not have been possible without the support and generous funding from the Cancer Prevention Research Institute of Texas (CPRIT). Dennis McWilliams, CEO and President for Apollo Endosurgery®, says, "Apollo Endosurgery is honored to be among the first of three companies in Texas to have received a commercialization grant from CPRIT. We've used these funds to advance therapeutic flexible endoscopy and other less invasive therapies. We're excited to see the application of our tools in the endoluminal removal of lesions from the stomach."

CPRIT is a state agency dedicated to expediting innovation and commercialization in the area of cancer research and to enhancing access to evidence-based prevention programs and services throughout Texas.  Learn more about the work of CPRIT at

To learn more about flexible surgery instruments, including the OverStitch® Endoscopic Suturing System and the SuMO™ Tissue Access and Resection System develop by Apollo Endosurgery®, visit

About Apollo Endosurgery®, Inc.

Apollo Endosurgery®, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology.  Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas.  All of Apollo's products are compatible with existing flexible endoscope platforms.  Apollo Endosurgery® was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong.  The company is funded by PTV Sciences, H.I.G. Ventures and has received a grant from the Cancer Prevention Research Institute of Texas. 

For more information:
Ted Stephens
Director of Marketing
Apollo Endosurgery®, Inc.
512-328-9990 (o)
513-312-9161 (m)

Follow us on Twitter -

SOURCE Apollo Endosurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement
2. MonoSol Rx Issued Strategic US Patent Governing the Production of Pharmaceutical Films Containing Specific Drugs and Drug Classes
3. ABSTRAL® (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.
4. Bayer Gets $100M Gender Class Action Headache
5. Life Technologies Initiates Clinical Trials Leading to 510(k) Submission of a Class I and Class II HLA Sequence-Based Typing Solution
6. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
7. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
8. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
9. Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits
10. K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock
11. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... -- The total global healthcare industry is expected to grow at ... America has the highest projected growth at 12.7%, ... ), is second with growth projected at 11.5%. ... expenditure. In 2013-2014, total government funded healthcare was nearly 68%. ... 41.2% in 2013-2014. In real terms, out of pocket expenditure ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... 2015 , ... Trying to relax on a couch can actually be uncomfortable, ... this design due to personal experience with a bad back," he said. , This ... as well as increases support. It also makes it easier to eat, do other ...
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the 21st ... not been an easy question to answer. Especially when the senior partners and lawyers ... share the same discipline around working long hours. , In addition to this ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... November 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South ... 750,000. The digital component is distributed nationally, through a vast social media strategy ...
Breaking Medicine News(10 mins):